Link da publicação
Este post tem mais dois artigos sobre o assunto, em português:
1 – Vacinas x Autismo: EUA Recompensou Secretamente por Danos pela Vacina 83 Crianças que Ficaram Autistas
O Governo dos EUA sempre negou a ligação entre autismo e vacinas. No entanto, o governo americano secretamente recompensou no Juizado Especial da Vacina mais de 83 famílias com crianças autistas, admitindo desta forma a correlação entre autismo vacinas. Aqui está um estudo sobre esta questão.
Por mais de 20 anos, o governo federal negou publicamente uma ligação entre a vacina e o autismo, mas ao mesmo tempo, seu “Programa de Compensação por Lesões Causadas Por Vacinas” (VICP) pagou indenizações por danos de vacinas para crianças com lesão cerebral, convulsão e autismo. Uma nova investigação, com base em dados verificáveis do governo, traz novas informações ao controverso debate sobre a ligação entre as vacinas e o autismo. A investigação revelou que um número substancial de crianças recompensadas por danos da vacina também tinham autismo e que esses casos que já existiam desde 1989, um ano após o VICP ter sido formado.
O Diretor Executivo da SafeMinds, Lyn Redwood, comentou: “Este estudo muda dramaticamente o debate sobre autismo e vacinas. A questão não é mais se é possível que as vacinas causem o autismo? A resposta é clara. Agora, temos de perguntar: Quantos casos de autismo as vacinas causaram e como nós podemos prevenir novos casos?” O governo tem afirmado que “não monitora” a ocorrência de autismo entre aqueles lesados por vacina. O SafeMinds responde que não procurar é a maneira mais fácil de não encontrar coisa alguma. SafeMinds está pedido uma imediata investigação federal nos mecanismos de lesão nestas crianças em um esforço de proteger outras crianças contra futuros danos, e pede também a ação do Congresso para
reformar o VICP.
O estudo peer-reviewed analisou os casos de lesão por vacinas que foram recompensados monetariamente pelo Programa Federal por Danos de Vacinas. O estudo foi publicado duas semanas atrás no jornal acadêmico Pace Environmental Law Review. O estudo investigou aproximadamente 1.300 casos de lesão cerebral infantil como resultado de vacinas em que o Juizado Especial da Vacina deu o ganho de causa para os demandantes, em busca de referências ao autismo, sintomas de autismo ou desordens comumente associadas ao autismo. O estudo mostrou que 21 casos realmente mencionavam “autismo ou os sintomas como os do autismo” nos registros do tribunal. Os pesquisadores então identificaram e contataram as mais de 150 famílias recompensadas pelo tribunal para descobrir se as crianças tinham autismo. Eles foram capazes de encontrar um adicional de 62 casos (superior a 40% de sua amostra) totalizando 83 casos de autismo. Em 39 casos (47%) houve confirmação de autismo, além do próprio reporte dos pais.
O governo federal americano tem chamado o autismo de uma “emergência de saúde nacional”, que afeta pelo menos 1 em cada 110 crianças e custa ao país bilhões de dólares a cada ano. Se uma parcela destes casos de autismo são induzidas pelas vacinas e houver evidências de que os funcionários fizeram “vista grossa”, isto não pode ser tolerado. A recente tentativa do VICP de recusar mais de 5.000 casos do Omnibus Autism Proceedings é suspeito à luz destas novas descobertas com base em seus próprios registros.
* [ESTUDO] Unanswered Questions from the Vaccine Injury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury (PDF)
* Vigilant Citizen: Government Secretly Settled 83 Vaccine-Autism Cases in the Last 20 Years
* Pr News Wire: 83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
* Safeminds Press-Release
O tribunal determinou que Bailey não teria sofrido este atraso se não fosse pela administração da vacina tríplice … uma sequência próxima de causa e efeito levando inexoravelmente da vacina ao PDD [Autismo].”- Banks vs Secretário do Departamento de Saúde e Serviços Humanos [EUA].
O tribunal determinou que Bailey não teria sofrido este atraso se não fosse pela administração da vacina tríplice … uma sequência próxima de causa e efeito levando inexoravelmente da vacina ao PDD [Autismo].”
– Banks vs Secretário do Departamento de Saúde e Serviços Humanos [EUA]
Uma criança não deveria ter que enfrentar sozinha uma indústria inteira.
Hoje, num exclusivo do Huffington Post, Robert F. Kennedy Jr. e o jornalista de investigação David Kirby revelam que no recente caso de Bailey Banks vs. HHS, o tribunal de vacinas [dos EUA]determinou que as vacinas foram a causa do autismo de Bailey e ordenaram que a sua família fosse compensada.
Banks é o segundo caso onde o governo não pôde negar a evidência esmagadora demonstrando que as vacinas foram a causa do autismo da criança. O primeiro foi o caso de Hannah Poling em Março de 2008. O governo aceitou a decisão e entregou as indemnizações à sua família.
Pequenas vitórias para estas crianças, mas que dizer das centenas de milhares de outras famílias debatendo-se com o autismo? Nesta contínua controvérsia vacina-autismo em quem podem acreditar e no quê?
O Congresso criou o misterioso tribunal de vacinas em 1986, por insistência da indústria farmacêutica, o qual não só protegeu os produtores de vacinas de responsabilidade como levou à triplicação do número de vacinas que são ministradas aos nossos filhos. Porque é que existe o tribunal de vacinas? Porque é que as decisões em favor das crianças são suprimidas? Onde está a justiça para estes pais?
Nesta nova era de responsabilidade governamental e de transparência, as uma em 64 famílias que têm que se debater com o autismo merecem mais. Já é tempo de o governo dizer a verdade sobre vacinas infantis.
Pra quem fica taxando isso de “teorias conspiratórias” e não procura investigar as coisas antes de afirmar algo ou conceituar sobre algum tema, ficará difícil engolir isso a “seco” agora.
Segundo este artigo publicado em revista de pediatria americana, o autismo estaria relacionado com falta de vitamina D.
E parte do tratamento seriam suplementos de vitamina D.
Evidence is mounting that vitamin D deficiency is intimately involved in autism. We report on autism prevalence by US state for those aged 6–17 y in 2010 with respect to indices of solar UV-B (UVB) doses. We calculated autism prevalence rates for white, black and Asian Americans by using total prevalence and relative populations of minors for each ethnic group by state. Analyses omit AK and HI (considered extreme cases), WY (no data), along with AZ and ND for black Americans (low numbers) and DC, ME, MT, ND and SD for Asian Americans (low numbers). For white Americans, the regression coefficient for solar UVB doses and autism prevalence ranged from -0.52 in January to -0.57 in October. For black Americans, the regression coefficient for latitude was 0.61, whereas those for solar UVB ranged from -0.55 to -0.61. For Asian Americans, the values for solar UVB ranged from -0.28 to -0.38. The inverse correlation between solar UVB and autism prevalence is similar to that for many types of cancer in the US. The journal literature indicates that adverse effects on fetal brain development during pregnancy due to vitamin D deficiency can explain these findings. However, we cannot rule out a role of vitamin D deficiency in early life. These results add to the evidence that vitamin D deficiency may be an important risk factor for autism and suggest that pregnant women and autistic individuals raise their serum 25-hydroxyvitamin D concentrations above 30 ng/ml.
Evidence is mounting that vitamin D deficiency is a risk factor for autism. Cannell1  first proposed and later extended2  the UV-B (UVB)-vitamin D-autism hypothesis. Kinney and colleagues3 reviewed the autism and vitamin D connection and suggested that “Vitamin D plays important roles in repairing DNA damage and protecting against oxidative stress—a key cause of DNA damage.” Mostafa and Al-Ayadhi recently studied autistic children and found a strong correlation between better autism rating scales and higher 25(OH)D levels and between higher anti-neural antibodies and lower 25(OH)D levels.4 Kočovská and colleagues5 reviewed the evidence supporting this hypothesis and called for “urgent research” into vitamin D and autism. Despite the mounting evidence, the working hypothesis has not been accepted among autism researchers. .
A map of autism rates by state for children aged 6–17 y in the Los Angeles Times in December 20116 prompted this ecological study. The map showed highest rates in the Northeast and on the West Coast and lowest among the Southern and Plains states. The trend of high rates in the Northeast and lowest rates in the Southern states is similar to that of many types of cancer,7 which were linked to solar UVB doses for July.8,9Thus, we thought that the data, when analyzed in greater detail, might show an inverse correlation between solar UVB doses and prevalence of autism.
Table 1 gives the regression results for solar UVB doses for several different months as well as latitude. For white and Asian Americans, the regression fits for UVB in March, July and October were similar and stronger than those for UVB in January or latitude. However, for black Americans, the results for latitude were similar to those for UVB. The regression fits for black Americans were slightly stronger than for white Americans.
Table 1. Regression results, autism aged 6–17 y in the US in 2010 by state
|Race, states||Factor||Linear fit (r, adjusted R2, p)||Power law fit (r)|
|White Americans (AK,
HI, WY omitted)
|UVB-vit D, Oct||-0.57, 0.31, *||0.60|
|UVB-vit D Mar||-0.55, 0.29, *||0.58|
|UVB Jul||-0.55, 0.28, *||0.57|
|UVB-vit D, Jul||-0.54, 0.28, *||0.60|
|UVB-vit D, Jan||-0.52, 0.25, *||0.52|
|Latitude||0.48, 0.22, *||0.48|
|Black Americans (AK, AZ, HI, ND, WY omitted)||Latitude × latitude||0.63, 0.38, *||0.63|
|Latitude||0.61, 0.36, *||0.63|
|UVB-vit D, Oct||-0.61, 0.36, *||0.69|
|UVB-vit D Mar||-0.59, 0.33, *||0.62|
|UVB Jul||-0.57, 0.31, *||0.60|
|UVB-vit D, Jan||-0.56, 0.31, *||0.65|
|UVB-vit D, Jul||-0.55, 0.29, *||0.63|
|Asian Americans (AK, DC, HI, ME, MT, ND, SD, WY omitted)||UVB-vit D, Jul||-0.38, 0.13, 0.01||0.38|
|UVB Jul||-0.36, 0.11, 0.02||0.35|
|UVB-vit D, Oct||-0.32, 0.08, 0.04||0.33|
|UVB-vit D Mar||-0.30, 0.07, 0.06||0.30|
|Latitude × latitude||0.29, 0.06, 0.06||0.27|
|Latitude||0.28, 0.05, 0.08||0.27|
|UVB-vit D, Jan||-0.28, 0.05, 0.08||0.34|
, p < 0.001; UVB-vit D, data for vitamin D production from UVB;12 UVB Jul, data from reference 54.
No significant correlations emerged for other possible risk-modifying factors such as air pollution, alcohol consumption, obesity, poverty, or smoking.
Figures 1–3 are scatter plots of the autism prevalence data with respect to solar UVB doses. Figure 1 shows the results for white Americans with respect to October UVB vitamin D production with both linear and power-law fits to the data. Figure 2 does the same for black Americans. Figure 3shows the results for Asian Americans with respect to July UVB vitamin D production. The linear regression fits to the data show ratios for low to high UVB of 2.4 for white Americans, 3.6 for black Americans and 1.7 for Asian Americans. In all three cases, prevalence of autism with respect to changes in solar UVB decreases faster at lower UVB doses than at higher doses.
Figure 1. Scatter plot of autism prevalence for white Americans vs. solar UVB doses for October13 with linear and power-law fits to the data. Prevalence data are in arbitrary units. Omitted states: AK, HI and WY.
Figure 3. Same as Figure 1 but for Asian Americans. Omitted states: AK, DC, HI, ME, MT, ND, SD and WY.
The finding that, for both white and Asian Americans, solar UVB doses for March, July and October are much stronger than UVB doses in January or latitude suggests that vitamin D’s effect is associated with vitamin D production from solar UVB when doses are relatively high. This finding is similar to those for many types of cancer.8,9 Other ecological studies directly correlated multiple sclerosis prevalence rates with latitude.10,11 The latitudinal dependence in the United States is considered an index of wintertime solar UVB doses12 because summertime solar UVB doses are highly asymmetrical, being highest in the Southwest and lowest in the Northeast.13 Low serum 25(OH)D concentrations in winter are associated with infectious diseases such as influenza,14 which peaks in winter. However, for black Americans, the results for latitude are comparable to those for UVB.
If we assume that solar UVB production of vitamin D is an important factor in reducing risk of autism, an important question is how vitamin D deficiency before and during pregnancy and in early life affects risk. Reasonable evidence exists that autism is due in part to genetic factors. For example, evidence indicates that vitamin D status affects both male and female fertility,15 which could be due to potential genetic effects on the fetus. In addition, monozygotic twins are more likely to be concordant for autism than dizygotic twins.16 Good evidence also exists that vitamin D deficiency during pregnancy leads to adverse birth outcomes. Maternal metabolic conditions during pregnancy (diabetes, hypertension and obesity) are associated with increased risk of offspring diagnosed with autism by age 5 y.17 Vitamin D deficiency is a risk factor for diabetes,18and obesity is associated with lower serum 25(OH)D concentrations.19 Animal model studies have documented adverse effects on fetal brain development for vitamin D-deficient mothers.20 Although prompted by an interest in schizophrenia, Sullivan and colleagues21 associated family history of schizophrenia with increased risk of autism.
A study in Australia “found that the risk of women with vitamin D insufficiency (≤46 nmol/L) during pregnancy having a child with clinically significant language difficulties was increased close to twofold compared with women with vitamin D levels >70 nmol/L.”22 A study in the UK found that there were excess birth rates in April for several immune-mediated diseases found to be related to vitamin D deficiency in other studies, thereby providing evidence that vitamin D deficiency during fetal development is a risk factor for these diseases.23
Season of birth (or conception) affects risk of autism. In the 1980s and 1990s, excess birth rates for autism occurred around March.24,25However, Zerbo and colleagues26 associated wintertime conception with increased risk of autism. Maternal infection during pregnancy is associated with increased risk of autism,3,27 as is elevated maternal temperature. See Edwards29 for an explanation of how infection through increasing body temperature, is a risk factor for adverse birth outcomes.
Vitamin D reduces risk of both bacterial and viral infection.30 Lower respiratory infections are relatively common during pregnancy.31 Influenza infection during pregnancy is associated with increased risk of schizophrenia in offspring.32 Vitamin D may reduce the risk of influenza32,33 as well as that of other acute respiratory infections.34
A study in Denmark found significantly increased risk of epilepsy for those born to mothers who experienced elevated temperature during pregnancy associated with infections.35 Both epilepsy and autism have elevated birth rates in winter and lower birth rates in summer or fall.24,36
Although the journal literature supports the evidence for vitamin D deficiency before or during pregnancy as an important risk factor for autism, this ecological study cannot determine whether vitamin D status after birth plays a role although Mostafa and Al-Ayadhi’s recent study indicates such a connection.4 Both genetics and environment affect risk of autism.16 However, separating genetic from environmental factors is difficult.37
Since differences were found for those with different skin pigmentation, there might be some effects of solar irradiance other than vitamin D production involved in the link between solar UVB doses and prevalence of autism. A number of papers have reviewed the neuroendocrinology of the skin.38–41 For example, keratinocytes stimulated by UVR can produce and secrete a number of cytokines.38 A recent study found that children with autism were “more likely to have decreased levels of both T helper-1(Th-1)-like cytokines (i.e. IFN-γ) and Th-2like cytokines (i.e. IL-4, IL-10).”42 Since darker pigmentation reduces the effect of UVR on keratinocytes, those with darker skin should produce fewer cytokines. Certainly more research is needed in this area.
UVA can increase serotonin production and reduce melatonin concentrations.43 “Low maternal plasma serotonin may be a risk factor for autism through effects on fetal brain development..”44 Those with autism may have a deficit of melatonin since supplementing them with melatonin improves sleep patterns.45 Since dark skin reduces the production of serotonin and degradation of melatonin, those with lighter skin have an decreased risk of autism and a recent review showed the opposite.46 Obviously, more work needs to be done in this area.
There is some evidence that UVR contributed to regulation of the hypothalamic-pituitary-adrenal (HPA) axis and the inflammatory response system and that they may have systemic effects.41 Prenatal stressors should increase the risk of autism and maternal stress during pregnancy is weakly associated with raised maternal cortisol.47 Thus, more research is needed in this area.
Vitamin D recommendations
The Institute of Medicine determined that pregnant women require only 600 IU/d (15 µg/day) of vitamin D3 (recommending the same for a 300-pound professional football lineman) and opine that a serum 25(OH)D concentration of 20 ng/ml is adequate.48 In the US, serum 25(OH)D concentrations during pregnancy are already low,49,50 and black Americans have much lower serum 25(OH)D concentrations than white Americans in general.51 The optimal serum 25(OH)D concentration during pregnancy is above 30 ng/ml based on a number of observational studies. Representative studies reporting that levels above 30 ng/ml are optimal include those related to pregnancy outcomes such as bacterial vaginosis,52 birth weight,53 primary Cesarean section delivery,54 and pre-eclampsia.55 In addition, gestational 25(OH)D concentrations are associated with normal fetal brain development20,56 and levels above 30 ng/ml are associated with reduced risk of childhood neuropsychological impairments,57 and development language difficulties.58
There is also evidence that serum 25(OH)D concentrations above 40 ng/ml might be considered optimal during pregnancy since optimal production of 1,25-dihydroxyvitamin D was achieved above this value in a randomized controlled trial with pregnant women.59,60 No adverse effects on calcium metabolism or other parameters were apparent in pregnant women taking 4000 IU/d of vitamin D3.60 A recent study of 25(OH)D levels in women living a traditional life style near the equator found mean serum 25(OH)D levels of nearly 60 ng/ml in pregnancy, approximately triple that of pregnant women in more developed poleward countries who putatively live and work indoors.61
The optimum 25(OH)D levels for children with autism are unknown although Mostafa and Al-Ayadhi found a strong negative correlation between autism rating scales and 25(OH)D levels in children with autism.4 They did not report a flattening of the association with higher vitamin D levels and improved autism scores although their study was limited by both the sample size and the low number of children with higher vitamin D levels. They also found autistic children have lower 25(OH)D levels than do control children although both groups reported similar time outdoors.
Mean “natural” 25(OH)D levels (as opposed to “normal” 25(OH)D levels) are around 46 ng/ml, as recently discovered by Luxwolda et al. who studied 25(OH)D levels of hunter-gatherers in equatorial Tanzania.62 Such “natural” 25(OH)D levels were common among tanned lifeguards in Missouri.63
This ecological study finds that autism prevalence among those aged 6–17 y in 2010 was significantly inversely correlated with solar UVB doses. Taken together, these results and other findings strongly implicate vitamin D deficiency as an important risk factor for developing autism. Maternal vitamin D deficiency appears to play an important role although we cannot discount a role of vitamin D deficiency in early life. Further studies should evaluate the UVB-vitamin D-autism hypothesis in both pregnant women and children with autism.
WBG obtained prevalence data from the Data Accountability Center associated with the Individuals with Disabilities Education Act data. The numbers of children by state with autism in 2010 are from Part B, Child Count (https://www.ideadata.org/PartBChildCount.asp (accessed Dec 16, 2011). Data used included the number of children with autism aged 6–17 y; those aged 6–21 y; and number of Asian, black and white children aged 6–21 y with autism. The data for those aged 6–17 y were not separated by race. WBG used the data by race for those aged 6–21 y with autism to estimate the number by race of those aged 6–17 y.
The data for total population aged 6–17 y by state are from Part C, Population and Enrollment Data, Table C-4, Number of and percentage change in estimated resident population ages 6–17, by state: 2001, 2009 and 2010 (https://www.ideadata.org/PopulationData.asp#2010[accessed Dec 16, 2011]).
WBG calculated the estimated population by race and state for children aged 6–17 y, he calculated numbers of autism children for each race and state. WBG obtained racial populations by state for children aged 5–17 y in 2009 from the US. Census Bureau (http://www.census.gov/compendia/statab/cats/population/estimates_and_projections_by_age_sex_raceethnicity.html [accessed Dec 18, 2011]). The fractions for single races were as follows: white (including Hispanics), 0.760; black, 0.151; and Asian, 0.043. WBG used these values to apportion the population by state into the three racial categories to calculate autism rates by race and state.
The independent variables used in this ecological study were solar UVB doses and latitude. WBG used two sets of data for UVB doses. One was DNA-weighted surface UVB doses from the Total Ozone Mapping Spectrometer (TOMS) for noon for July 1992.64 Grant and Garland9 used these data in an ecological study of cancer mortality rates. The other data set was monthly solar UVB doses weighted for vitamin D production from TOMS, validated using ground-based measurements and averaged over the period 1980–1990 for 12:00–12:59 p.m. local time.13 Solar UVB doses in the US in summer are highly asymmetric, with levels highest in the Southwest, lowest in the Northeast. The reasons for this asymmetry include that surface elevations are higher in the West, whereas stratospheric ozone column contents are lower. In addition, the Northeast has greater aerosol loading and cloud cover. For both sets of data, WBG estimated the UVB dose for each state from the maps in an effort to weight it by each state’s population distribution. A problem with the data maps from Fioletov and colleagues is that the contours are closely spaced in the Southwest, making this graphical approach less reliable for those states.
Latitude is an index for wintertime solar UVB dose and vitamin D production because solar zenith angle is much more important in winter than is surface elevation and stratospheric ozone column content. WBG chose latitude data to be near the center of population for each state. The second-order regression with latitude yielded the best model for multiple sclerosis prevalence among veterans of World War II and the Korean War in the US10 Scientists have linked multiple sclerosis to the Epstein-Barr virus, and other diseases linked to this virus have peak rates in March.65
This report omits data for AK and HI because those states are at the extreme latitudes and were not used in other ecological studies such as those regarding solar UVB and cancer.8 No data were available for Wyoming. In addition, some states have few Asians and/or blacks with autism, yielding poor estimates of autism rates. For black Americans, analyses omitted AZ and ND. For Asian Americans, DC, ME, MT, ND and SD were also omitted.
The analyses also used data for several possible risk-modifying factors, as has been done for cancer.9 These factors included alcohol consumption, lung cancer mortality rates for females, obesity, fraction of population living below poverty level and particulate air pollution concentrations.
WBG conducted linear regression analyses with the SPSS 20.0 statistical package (IBM/SPSS, Chicago, IL) and power law regression analyses with KaleidaGraph version 4.02 (Synergy Software, Reading, PA). Graphs were prepared using KaleidaGraph.
W.B.G. receives funding from the UV Foundation (McLean, VA), Bio-Tech Pharmacal (Fayetteville, AR), the Vitamin D Council (San Luis Obispo, CA), the Vitamin D Society (Canada) and the Sunlight Research Forum (Veldhoven). J.J.C. is president of the Vitamin D Council and receives remuneration from Purity Products, Inc.